Stonnington Group, LLC Zoetis Inc. Transaction History

Stonnington Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 08, 2022	BUY	$155.97 - $200.09 $233,955 - $300,135	1,500 Added 107.14%	2,900 $519,000
Q1 2022 Apr 12, 2022	SELL	$181.39 - $234.03 $1.52 Million - $1.97 Million	-8,400 Reduced 85.71%	1,400 $270,000
Q4 2021 Jan 12, 2022	BUY	$193.69 - $247.03 $38,738 - $49,406	200 Added 16.67%	1,400 $298,000
Q4 2021 Jan 12, 2022	BUY	$193.69 - $247.03 $1.63 Million - $2.08 Million	8,400 Added 600.0%	9,800 $2.09 Million
Q3 2021 Oct 12, 2021	SELL	$189.29 - $209.69 $378,580 - $419,380	-2,000 Reduced 62.5%	1,200 $237,000
Q2 2021 Jul 09, 2021	BUY	$155.9 - $187.99 $155,900 - $187,990	1,000 Added 45.45%	3,200 $630,000
Q1 2021 May 21, 2021	BUY	$144.0 - $169.39 $316,800 - $372,657	2,200 New	2,200 $370,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonnington Group, LLC with notifications on news.